Description

Von Korff et al developed a Chronic Disease Score (CDS) that evaluates a patient's chronic disease status based on the need for drug therapy. This can be derived using information stored in pharmacy computer databases. The authors are from the Group Health Cooperative of Puget Sound in Seattle, Washington.


 

Chronic Disease

Medication Classes

Points

heart disease

(1) anticoagulants, hemostatics

(2) cardiac agents, ACE inhibitors

(3) diuretic loop

3 points for 1 class

4 points for 2 classes

5 points for 3 classes

respiratory illness

(1) isoproterenol

(2) beta-adrenergic agent

(3) xanthine products

(4) respiratory products such as bronchodilators and mucolytics but excluding cromolyn

(5) epinephrine

2 points for 1 class

3 points for 2+ classes

asthma, rheumatism

glucocorticoids

3

rheumatoid arthritis

gold salts

3

cancer

antineoplastics

3

Parkinson's

L-dopa

3

hypertension

(1) antihypertensives (except ACE inhibitors) or calcium channel blockers

(2) beta blockers, diuretics

1 point if class 2 only

2 point if class 1

diabetes

insulin, oral hypoglycemics

2

epilepsy

anticonvulsants

2

asthma, rhinits

cromolyn

2

acne

(1) antiacne tretinoin

(2) topical macrolides

1 point if either class with 2+ prescriptions

ulcers

cimetidine

1

glaucoma

ophthalmic miotics

1

gout, hyperuricemia

uric acid agents

1

high cholesterol

antilipemics

1

migraines

ergot derivatives

1

tuberculosis

antitubercular agents

1

after Table 1, page 199

 

chronic disease score =

= SUM(points for chronic disease medications)

 

Interpretation:

• minimum score: 0

• maximum score: 36

• The higher the score, the more likely that the patient will be hospitalized and/or die.

 

Limitations:

• Some of the agents described are no longer commonly prescribed, while newer agents for treating the conditions are not listed.

• Some chronic infections like AIDS or viral hepatitis C are not represented.

 


To read more or access our algorithms and calculators, please log in or register.